Drug intelligence / Profile preview

Ocurest New

Development stage
Unknown
Lead developer
Centaur Pharmaceuticals
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Ocurest New is an ophthalmic solution developed by Centaur Pharmaceuticals for the management of ocular allergy, eye irritation, and dry eye symptoms. It is a fixed-dose combination containing boric acid, borax, zinc sulphate, and menthol. Boric acid and borax serve as mild antiseptics and buffering agents that help maintain ocular hygiene and a balanced pH. Zinc sulphate acts as an astringent to relieve redness and congestion by clearing mucus and soothing the ocular surface. Menthol provides a cooling and refreshing sensation by activating the cold-sensitive TRPM8 receptors, thereby alleviating eye strain and discomfort caused by environmental factors such as dust, pollution, or prolonged screen time.

Brand names
Ocurest NewOcurest New Sterile Eye Drops
Other names
Ocurest New Eye Drops
02

Targets

TRPM8 (Transient receptor potential cation channel subfamily M member 8)

Beyond the preview

Go deeper on Ocurest New.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ocurest New.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call